Disseminated Coccidioidomycosis in a Patient with Normal Immunity: An Emerging Public Health Challenge with Geographic Expansion
-
September 1, 2026
Clinical Report: Disseminated Coccidioidomycosis in a Patient with Normal Immunity
Background
Coccidioidomycosis is a fungal infection caused by Coccidioides immitis and Coccidioides posadasii, primarily affecting individuals in arid regions of the western United States and parts of Latin America. Traditionally associated with immunocompromised patients, coccidioidomycosis can also occur in immunocompetent individuals.
Data Highlights
No numerical data or trial data presented in the article.
Key Findings
- A 41-year-old immunocompetent man was diagnosed with disseminated coccidioidomycosis after presenting with chest pain and skin nodules.
- Initial misdiagnosis included bronchopneumonia and presumed tuberculosis, delaying appropriate treatment for over three months.
- Final pathology confirmed Coccidioides infection with characteristic spherules and endospores.
- Despite severe disease, the patient could not continue treatment with intravenous amphotericin B due to lack of insurance and housing.
Clinical Implications
Clinicians should maintain a high index of suspicion for coccidioidomycosis in patients presenting with respiratory symptoms and skin lesions, especially in endemic areas.
Conclusion
The case underscores the need for increased awareness of disseminated coccidioidomycosis, particularly as its incidence rises among immunocompetent patients in changing geographic landscapes.
Related Resources & Content
- Open Forum Infectious Diseases, 2021 -- A Comparative Analysis of Coccidioidomycosis Patients in Arizona and California Based on Commercial Health Insurance Claims
- Open Forum Infectious Diseases, 2021 -- Hospitalizations Related to Coccidioidomycosis in the United States from 2016 to 2021
- Annals of Internal Medicine: Clinical Cases, 2025 -- Disseminated Emergomyces canadensis Infection in an Immunocompromised Male Patient from New Mexico
- IDSA 2016 Clinical Practice Guideline for the Treatment of Coccidioidomycosis
- Open Forum Infectious Diseases — Analyzing the Geographic Spread of Dimorphic Mycoses Through a US Commercial Insurance Database
- MMWR, Volume 75, Issue 6 -- February 19, 2026
- IDSA 2016 Clinical Practice Guideline for the Treatment of Coccidioidomycosis
- MMWR, Volume 75, Issue 6 — February 19, 2026
Based on findings from:
Disseminated Coccidioidomycosis in an Immunocompetent Host: A Geographically and Rapidly Expanding Public Health Concern
Annals Of Internal Medicine: Clinical Cases, 2026.
https://www.acpjournals.org/doi/10.7326/aimcc.2026.0494
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.